Capital Fund Management S.A. Bristol Myers Squibb CO Transaction History
Capital Fund Management S.A.
- $34.5 Billion
- Q2 2025
A detailed history of Capital Fund Management S.A. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Fund Management S.A. holds 304,174 shares of BMY stock, worth $14 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
304,174
Previous 1,795,900
83.06%
Holding current value
$14 Million
Previous $110 Million
87.15%
% of portfolio
0.04%
Previous 0.33%
Shares
23 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.5MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.98 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.31 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.98 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...